CellWell record HH-227001
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients
Shearwood McClelland; Melissa Brately; Raed J. Zuhour; Yilun Sun; Daniel E. Spratt
American Journal of Clinical Oncology ยท 2024
In plain language
Among trial-eligible spine cancer patients, 20% experienced insurance denials for radiation therapy, but peer-to-peer authorizations citing guidelines and evidence reversed all denials.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-227001
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.